Data presented here extend those observations by showing that pulmonary rather than systemic IL-17A is important for obesity-related AHR and suggest that changes in pulmonary Cfd expression contribute to the AHR-promoting effects of IL-17A. The gene discussed is AHR; the disease is obesity due to melanocortin 4 receptor deficiency.